Recon: Novo restarts shipments of 1.7 mg dose of Wegovy in US; FDA approves Merck’s Keytruda combo for expanded cervical cancer use
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States